Slovenië - Sloveens - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

metformin; sitagliptin - filmsko obložena tableta - metformin 662,9 mg / 1 tableta  sitagliptin50 mg / 1 tableta; sitagliptin 50 mg / 1 tableta - metformin in sitagliptin

Slovenië - Sloveens - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

metformin; sitagliptin - filmsko obložena tableta - metformin 662,9 mg / 1 tableta  sitagliptin50 mg / 1 tableta; sitagliptin 50 mg / 1 tableta - metformin in sitagliptin

Slovenië - Sloveens - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

metformin; vildagliptin - filmsko obložena tableta - metformin 662,88 mg / 1 tableta  vildagliptin50 mg / 1 tableta; vildagliptin 50 mg / 1 tableta - metformin in vildagliptin

Slovenië - Sloveens - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

metformin; vildagliptin - filmsko obložena tableta - metformin 779,86 mg / 1 tableta  vildagliptin50 mg / 1 tableta; vildagliptin 50 mg / 1 tableta - metformin in vildagliptin

Europese Unie - Sloveens - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin - diabetes mellitus, tip 2 - zdravila, ki se uporabljajo pri diabetesu - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.

Europese Unie - Sloveens - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin - diabetes mellitus, tip 2 - dipeptidyl peptidase 4 (dpp-4) inhibitors, drugs used in diabetes - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 in 5. 1 za razpoložljive podatke o različnih kombinacijah).

Europese Unie - Sloveens - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin - diabetes mellitus, tip 2 - zdravila, ki se uporabljajo pri diabetesu - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 in 5. 1 za razpoložljive podatke o različnih kombinacijah).

Slovenië - Sloveens - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

tableta - betahistin

Slovenië - Sloveens - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

sanolabor, d.d. - kolistin - tableta - kolistin 2000000 i.e. / 1 tableta - kolistin

Slovenië - Sloveens - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

metformin; sitagliptin - filmsko obložena tableta - metformin 780 mg / 1 tableta  sitagliptin50 mg / 1 tableta; sitagliptin 50 mg / 1 tableta - metformin in sitagliptin